Clinical trial
South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2…
NCT00121966 · Odense University Hospital, Other · Completed
Key facts
| NCT number | NCT00121966 |
|---|---|
| Title | South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus |
| Official title | South Danish Diabetes Study: A Prospective Randomised Multi-Centre Study for the Evaluation of the Optimal Pharmacological Antidiabetic Treatment of Type 2 Diabetes Mellitus |
| Acronym | SDDS |
| Lead sponsor | Odense University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Insulin Aspart, Insulin NPH, Metformin, Rosiglitazone |
| Enrollment | 400 |
| Start date | Jan 1, 2003 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jul 21, 2005 |
| Last update posted | Jun 19, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: